MODERATE — Monitor Closely
FDA warfarin label lists statins. Clinical significance is moderate. INR monitoring recommended when initiating or changing statin dose.
Evidence level: STRONG
Simvastatin may slightly increase warfarin blood-thinning effect. While this is a less severe interaction than many on this list, your INR should be monitored when starting or adjusting statin therapy.
Statins may modestly potentiate warfarin anticoagulant effect. Mechanism not fully characterized but may involve CYP enzyme competition. FDA warfarin label lists several statins as potentially increasing effect.
Get your INR checked when starting simvastatin or changing the dose. The effect is usually modest but worth monitoring.
Take Simvastatin in the evening when hepatic cholesterol synthesis peaks (exception: atorvastatin and rosuvastatin have long half-lives and can be taken any time). Warfarin can be taken at a separate meal. Report unexplained muscle pain, weakness, or dark urine immediately.
Higher risk for: elderly patients, those with liver disease, history of GI bleeding, concurrent use of multiple blood thinners, recent surgery, vitamin K intake changes, alcohol use, or low body weight.
Slight increase in bruising or bleeding tendency
Check INR when starting or adjusting statin. Effect is usually modest. Continue both medications with monitoring.
This medication combination requires careful medical oversight. Your doctor or anticoagulation clinic can adjust doses or select alternatives with fewer bleeding risks. Frequent INR monitoring is essential.
Simvastatin may slightly increase warfarin blood-thinning effect. While this is a less severe interaction than many on this list, your INR should be monitored when starting or adjusting statin therapy.
Take Simvastatin in the evening when hepatic cholesterol synthesis peaks (exception: atorvastatin and rosuvastatin have long half-lives and can be taken any time). Warfarin can be taken at a separate meal. Report unexplained muscle pain, weakness, or dark urine immediately.
Slight increase in bruising or bleeding tendency
This medication combination requires careful medical oversight. Your doctor or anticoagulation clinic can adjust doses or select alternatives with fewer bleeding risks. Frequent INR monitoring is essential.
Check INR when starting or adjusting statin. Effect is usually modest. Continue both medications with monitoring.
Or browse the full interaction database (121,000+ pairs).